biolitec AG Successfully Closes a Capital Increase against Cash Contribution

Jena, (PresseBox) - Today the company biolitec AG (Frankfurt, Prime Standard: BIB) successfully closed the capital increase decided upon on November 29, 2007. In an economic environment with a capital market marked by uncertainty, biolitec was able to acquire premium investors. The capital increase was carried out through an accelerated bookbuilding process. The Sole Lead Manager ICF Kursmakler AG has subscribed to 500,750 new biolitec shares and offered them to institutional investors in Germany and Europe. By issue of the new shares at an issue price of EUR 14.10 per share biolitec`s liquid funds increased by a gross amount of approx. EUR 7,060,000 million. Upon registration with the commercial register the company's share capital has increased to EUR 10,515,750, divided into the same number of shares.

The proceeds from the capital increase are intended for the further expansion of the sales force as well as for financing research and development projects in the future.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.